YoavHMessingerMD
Pediatric Hematology & Oncology • Minneapolis, MNPediatric Hematologist/Oncologist Children's Hospitals of Minnesota
Dr. Messinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2530 Chicago Ave
Minneapolis, MN 55404
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1993 - 1996- University of MinnesotaResidency, Pediatrics, 1991 - 1993
Tel Aviv University SacklerClass of 1985
Certifications & Licensure
MN State Medical License 1993 - 2025
WI State Medical License 2011 - 2023- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2006 Aug 04
- Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome Start of enrollment: 2005 Mar 01
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Bloodstream Infections in Childhood Acute Myeloid Leukemia and Machine Learning Models: A Single-institutional Analysis.Taylor L Chappell, Ellen G Pflaster, Resty Namata, Jometa Bell, Lane H Miller
Journal of Pediatric Hematology/oncology. 2025-01-01 - 1 citationsDICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance Strategies.Kris Ann P Schultz, Alexander T Nelson, Paige H R Mallinger, Anne K Harris, Junne Kamihara
Clinical Cancer Research. 2024-12-16 - National study reveals gram negative bacteremia on contemporary pediatric AML protocol.Nira Arad-Cohen, Yoav Messinger, Shlomit Barzilai-Birenboim, Miriam Ben-Harosh, Michal Golan-Malki
Leukemia & Lymphoma. 2024-12-01
Press Mentions
Triplet Regimen Active Against Relapsed/Refractory Pediatric AMLOctober 24th, 2017
Professional Memberships
- Member
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
